Prospective, randomized, double-blind trial of abrupt and tapered interruption of long-term clopidogrel therapy after implantation of a drug-eluting stent.

Trial Profile

Prospective, randomized, double-blind trial of abrupt and tapered interruption of long-term clopidogrel therapy after implantation of a drug-eluting stent.

Discontinued
Phase of Trial: Phase IV

Latest Information Update: 29 Jul 2016

At a glance

  • Drugs Clopidogrel (Primary)
  • Indications Cardiovascular disorders
  • Focus Therapeutic Use
  • Acronyms ISAR-CAUTION
  • Most Recent Events

    • 08 Feb 2014 Status changed from active, no longer recruiting to discontinued.
    • 11 Jun 2012 Status changed from recruiting to active, no longer recruiting as reported by ClinicalTrials.gov.
    • 04 Jan 2012 Planned end date changed from 1 Jun 2011 to 1 Jul 2012 as reported by ClinicalTrials.gov.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top